Cite
Zhong B, Shingyoji M, Hanazono M, et al. A p53-stabilizing agent, CP-31398, induces p21 expression with increased G2/M phase through the YY1 transcription factor in esophageal carcinoma defective of the p53 pathway. Am J Cancer Res. 2019;9(1):79-93
Zhong, B., Shingyoji, M., Hanazono, M., Nguyễn, T. T. T., Morinaga, T., Tada, Y., Hiroshima, K., Shimada, H., & Tagawa, M. (2019). A p53-stabilizing agent, CP-31398, induces p21 expression with increased G2/M phase through the YY1 transcription factor in esophageal carcinoma defective of the p53 pathway. American journal of cancer research, 9(1), 79-93.
Zhong, Boya, et al. "A p53-stabilizing agent, CP-31398, induces p21 expression with increased G2/M phase through the YY1 transcription factor in esophageal carcinoma defective of the p53 pathway." American journal of cancer research vol. 9,1 (2019): 79-93.
Zhong B, Shingyoji M, Hanazono M, Nguyễn TTT, Morinaga T, Tada Y, Hiroshima K, Shimada H, Tagawa M. A p53-stabilizing agent, CP-31398, induces p21 expression with increased G2/M phase through the YY1 transcription factor in esophageal carcinoma defective of the p53 pathway. Am J Cancer Res. 2019 Jan 01;9(1):79-93. eCollection 2019. PMID: 30755813; PMCID: PMC6356922.
Copy
Download .nbib